Literature DB >> 6879882

Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy.

S L Goldenberg, H N Fenster, Z Perler, M G McLoughlin.   

Abstract

Advanced carcinoma of the prostate may present as disseminated intravascular coagulation and its sequelae. It is postulated that the slow release of thromboplastic material from tumor cells eventually overcomes normal homeostatic mechanisms. High-dose intravenous diethylstilbestrol diphosphate successfully reversed this coagulopathy in 2 cases of metastatic carcinoma of the prostate.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6879882     DOI： 10.1016/0090-4295(83)90492-2

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  6 in total

1.  Prolonged remission of fulminant castrate-resistant prostate cancer: a case report.

Authors:  Mehmet Asim Bilen; Rosale General; Shi-Ming Tu
Journal:  Clin Genitourin Cancer       Date:  2011-05-14       Impact factor: 2.872

2.  Carcinoma of the prostate presenting as acute disseminated intravascular coagulation.

Authors:  D Grignon; D I Turnbull; R C Lohmann
Journal:  CMAJ       Date:  1986-10-01       Impact factor: 8.262

3.  Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations.

Authors:  Shirin Hussain; Mitchell G Lawrence; Renea A Taylor; Camden Yeung-Wah Lo; Mark Frydenberg; Stuart J Ellem; Luc Furic; Gail P Risbridger
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

4.  Very fast recovery of acute disseminated intravascular coagulation with abiraterone acetate in a patient with bone metastases from castrate-resistant prostate cancer.

Authors:  Hélène Gauthier; Camille Serrate; Damien Pouessel; Christine leMaignan; Luis Teixeira; Stéphane Culine
Journal:  Case Rep Oncol       Date:  2014-09-05

5.  Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix.

Authors:  Shawn Y Ong; Josephine Taverna; Clint Jokerst; Thomas Enzler; Emad Hammode; Elisa Rogowitz; Myke R Green; Hani M Babiker
Journal:  Case Rep Oncol Med       Date:  2015-11-03

6.  Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation.

Authors:  Lena Hell; Thomas Däullary; Vanessa Burghart; Lisa-Marie Mauracher; Ella Grilz; Bernhard Moser; Gero Kramer; Johannes A Schmid; Cihan Ay; Ingrid Pabinger; Johannes Thaler
Journal:  Cancers (Basel)       Date:  2021-03-24       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.